進升集團控股(01581.HK)年度扭虧為盈至2220萬港元
格隆匯6月27日丨進升集團控股(01581.HK)公吿,截至2024年3月31日止年度業績,年度的收入約為7.28億港元,較截至2023年3月31日止年度增加約42.6%。公司擁有人應占溢利約為2220萬港元,而截至2023年3月31日止年度公司擁有人應占虧損約為2200萬港元,扭虧為盈;年度的每股盈利約為5.36港仙,而截至2023年3月31日止年度每股虧損約為6.76港仙。董事會並不建議於本年度派付末期股息。
有關轉虧為盈狀況乃主要由於(i)集團承接的現有項目的新合約及變更令增加導致收入大幅增加及(ii)加強成本控制導致毛利率改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.